Retroviral transduction of T-cell antigen receptor beta-chain and myc genes.
Support for multistage models of oncogenesis has been provided by several highly leukaemogenic retrovirus isolates that have transduced more than one host cell gene. Where functional studies have been performed, these retroviral oncogenes show synergy for in vitro transformation and leukaemogenesis. In naturally occurring feline leukaemias associated with feline leukaemia virus (FeLV), retroviral transduction of myc is a frequent oncogenic mechanism. But evidence suggesting that the FeLV v-myc genes might be insufficient for leukaemogenesis was provided by the latency (12 weeks) and clonality of FeLV/v-myc-induced tumours and the absence of demonstrable in vitro transformation by these viruses. In the search for secondary leukaemogenic events in FeLV/v-myc tumours, we have identified a case of FeLV transduction of a T-cell antigen receptor beta-chain gene. The proviruses carrying this gene (which we have named v-tcr) were a separate population from those carrying v-myc. In its normal role, the T-cell receptor beta-chain forms part of a multimeric complex involved in antigen recognition and T-cell activation. We suggest that v-tcr is a novel viral oncogene which assisted v-myc in the genesis of a naturally occurring case of thymic lymphosarcoma.
D000818:Animals; D001483:Base Sequence; D002371:Cat Diseases / Q000235:genetics; D002415:Cats; D004273:DNA, Neoplasm / Q000235:genetics; D005256:Leukemia Virus, Feline / Q000235:genetics*; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics / Q000662:veterinary*; D009857:Oncogenes; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D012689:Sequence Homology, Nucleic Acid; D014161:Transduction, Genetic
D004273:DNA, Neoplasm; D011948:Receptors, Antigen, T-Cell